Literature DB >> 17487557

Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis.

Jean-Claude Marshall1, Andre Nantel, Paula Blanco, Josee Ash, Stephanie R Cruess, Miguel N Burnier.   

Abstract

Uveal melanoma is the most common primary intraocular tumor in adults and exclusively disseminates haematogenously in order to form metastases. The aim of this study was to measure the transcriptional profiles of human uveal melanoma cells isolated from a primary intraocular tumor, circulating malignant cells (CMCs), and metastases in order to elucidate the changes in gene expression associated with this progression. Human EST microarrays and universal reference RNA were used to measure the differences between tissue samples isolated from an immunosuppressed xenograft rabbit model of uveal melanoma. Cells were isolated from a single rabbit at the time of sacrifice from an intraocular tumor, peripheral blood, and metastasis. RNA was extracted from each sample and subjected to transcriptional profiling analysis. Results were compared to the transcriptional profiles previously obtained from the original cell line used for intraocular injections. Changes were verified using real-time PCR analysis. A total of 314 significant changes in gene expression were seen from the intraocular tumor to metastasis, as determined by transcript abundance. Principle Components Analysis was used to cluster these changes into four distinct groups. An additional 61 statistically significant changes were observed between the recultured and CMCs, with the latter believed to represent an intermediate step in the progression from intraocular tumor to metastasis. In conclusion, we have produced a detailed analysis of the transcriptional changes that take place as human uveal melanoma cells evolve from a primary tumor to metastasis in a xenograft animal model, including the decrease in expression of specific melanoma markers.

Entities:  

Mesh:

Year:  2007        PMID: 17487557     DOI: 10.1007/s10585-007-9072-z

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  32 in total

1.  Alpha-kinases: a new class of protein kinases with a novel catalytic domain.

Authors:  A G Ryazanov; K S Pavur; M V Dorovkov
Journal:  Curr Biol       Date:  1999-01-28       Impact factor: 10.834

2.  The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.

Authors:  M Diener-West; J D Earle; S L Fine; B S Hawkins; C S Moy; S M Reynolds; A P Schachat; B R Straatsma
Journal:  Arch Ophthalmol       Date:  2001-07

3.  The effect of blue light exposure and use of intraocular lenses on human uveal melanoma cell lines.

Authors:  Jean-Claude A Marshall; Keith D Gordon; Cristin S McCauley; João Pessoa de Souza Filho; Miguel N Burnier
Journal:  Melanoma Res       Date:  2006-12       Impact factor: 3.599

Review 4.  Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.

Authors:  M J Hendrix; E A Seftor; R E Seftor; L M Gardner; H C Boldt; M Meyer; J Pe'er; R Folberg
Journal:  Lab Invest       Date:  1998-02       Impact factor: 5.662

5.  Uveal melanoma model with metastasis in rabbits: effects of different doses of cyclosporine A.

Authors:  G Blanco; A M Saornil; E Domingo; Y Diebold; R López; G Rábano; C J Tutor
Journal:  Curr Eye Res       Date:  2000-09       Impact factor: 2.424

6.  MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes.

Authors:  Toshihiko Hoashi; Hidenori Watabe; Jacqueline Muller; Yuji Yamaguchi; Wilfred D Vieira; Vincent J Hearing
Journal:  J Biol Chem       Date:  2005-01-28       Impact factor: 5.157

7.  Role of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin.

Authors:  Mélanie Bérubé; Mariève Talbot; Charles Collin; Carine Paquet-Bouchard; Lucie Germain; Sylvain L Guérin; Eric Petitclerc
Journal:  Int J Oncol       Date:  2005-02       Impact factor: 5.650

8.  Immunohistochemical expression of phospho-Akt in uveal melanoma.

Authors:  Vinicius S Saraiva; Amanda L Caissie; Laura Segal; Chaim Edelstein; Miguel N Burnier
Journal:  Melanoma Res       Date:  2005-08       Impact factor: 3.599

9.  Survival rates with uveal melanoma in the United States: 1973-1997.

Authors:  Arun D Singh; Allan Topham
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

10.  Establishment and characterization of an uveal-melanoma cell line.

Authors:  I De Waard-Siebinga; D J Blom; M Griffioen; P I Schrier; E Hoogendoorn; G Beverstock; E H Danen; M J Jager
Journal:  Int J Cancer       Date:  1995-07-17       Impact factor: 7.396

View more
  11 in total

1.  Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma.

Authors:  Pierre L Triozzi; Wayne Aldrich; Arun Singh
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-25       Impact factor: 4.799

2.  Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma.

Authors:  John M Lattier; Hua Yang; Susan Crawford; Hans E Grossniklaus
Journal:  Clin Exp Metastasis       Date:  2013-06-22       Impact factor: 5.150

Review 3.  Animal Eye Models for Uveal Melanoma.

Authors:  Jinfeng Cao; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

4.  Uveal melanoma: Ocular and systemic disease.

Authors:  Cristina Miyamoto; Matthew Balazsi; Silvin Bakalian; Bruno F Fernandes; Miguel N Burnier
Journal:  Saudi J Ophthalmol       Date:  2012-04

Review 5.  Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.

Authors:  M Mimeault; S K Batra
Journal:  Panminerva Med       Date:  2008-03       Impact factor: 5.197

6.  In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases.

Authors:  Hua Yang; Guofu Fang; Xinping Huang; Jie Yu; Chia-Ling Hsieh; Hans E Grossniklaus
Journal:  Melanoma Res       Date:  2008-04       Impact factor: 3.599

7.  Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices.

Authors:  Sebastian Di Cesare; Andre Nantel; Jean-Claude Marshall; Bruno F Fernandes; Emilia Antecka; Maria E Orellana; Daniel Abourbih; Antonia M Saornil; Miguel N Burnier
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-13       Impact factor: 4.553

8.  Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines.

Authors:  Jonathan J Cools-Lartigue; Cristin S McCauley; Jean-Claude A Marshall; Sebastian Di Cesare; Francois Gregoire; Emilia Antecka; Patrick Logan; Miguel N Burnier
Journal:  Mol Vis       Date:  2008-01-10       Impact factor: 2.367

Review 9.  Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations.

Authors:  Marta M Stei; Karin U Loeffler; Frank G Holz; Martina C Herwig
Journal:  Biomed Res Int       Date:  2016-06-06       Impact factor: 3.411

Review 10.  Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives.

Authors:  Arnaud Martel; Stephanie Baillif; Sacha Nahon-Esteve; Lauris Gastaud; Corine Bertolotto; Barnabé Roméo; Baharia Mograbi; Sandra Lassalle; Paul Hofman
Journal:  Cancers (Basel)       Date:  2020-11-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.